Nicolas Danchin is Professor of Medicine at Université de Paris René Descartes, Consultant Cardiologist and Head of the Department of Coronary Artery Disease and Intensive Cardiac Care at the Hôpital Européen Georges Pompidou in Paris, France. He is also in charge of a large preventive medical centre (Investigations Préventives et Cliniques, IPC) in Paris, with over 20,000 people consulting for a health check-up each year. He has a special interest in coronary artery disease, its treatment modalities including interventional cardiology and its prevention. Professor Danchin received his medical degree at the University of Nancy, France, in 1980. After medical school, he received a Medical Internship at the University Hospital of Nancy. From 1978-1979, he was a co-operating physician at the Montreal Heart Institute in Montreal, Canada. From 1982-1984, he was Assistant Professor of Medicine, and from 1990–2000, Full Professor of Medicine, at the University Hospital of Nancy. Currently, he is the Head of the Department of Coronary Artery Disease and Intensive Cardiac Care in Paris, France, and a past President of the French Society of Cardiology. He is the current Chairman of the Working Group on Acute Cardiac Care of the European Society of Cardiology, and chairs the Experts’ Committee of the Acute Coronary Syndromes Euro Heart Survey. Professor Danchin has published more than 400 papers in peer-reviewed journals such as the American Journal of Cardiology, Archives of Internal Medicine, Circulation, Clinical Pharmacology and Therapeutics, European Heart Journal, Journal of the American College of Cardiology, Lancet, and New England Journal of Medicine. He is editor-in-chief of Annales de Cardiologie et Angéiologie and Consensus Cardio, and is on the editorial board of the European Heart Journal and Heart.
Hôpital Européen Georges Pompidou is the most recent institution of Assistance Publique des Hôpitaux de Paris, a network of academic hospitals in the Paris region. It opened in July 2000 and has approximately 200 beds devoted to cardiology, vascular diseases and cardiovascular surgery.
The aim of the ISCP in France is to constitute a forum for all physicians and scientists involved in the field of cardiovascular disease and aware of the crucial dole of medications in the management of cardiovascular patients. Scientists and physicians will find in the ISCP a way to promote clinical research on pharmacotherapy, to share their experience, and to be immediately informed of the most recent developments in cardiovascular pharmacotherapy. Topics of interest in the near future will cover antithrombotic therapy in acute coronary syndromes and in patients with atrial fibrillation, antiarrhythmic therapy, and treatment of acute heart failure, as well as novel medications in cardiovascular prevention.